Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06109649 · ClinicalTrials.gov registry record · Phase 3

A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo

A Phase 3 study of Vitiligo, sponsored by Clinuvel.

Active
Registry status
Phase 3
Development phase
200
Enrollment target
20
Study locations

NCT06109649 is a Phase 3 study of Vitiligo that is active but no longer recruiting, run by Clinuvel. The registered enrollment target is 200 participants, below the 1,111-participant average among 15 other Vitiligo trials with a reported enrollment target (82% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06109649, a Phase 3 study of Vitiligo, is active but no longer recruiting, sponsored by Clinuvel.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
200 participants
Enrollment target
20
Study locations

Study Summary

The CUV105 study will assess the efficacy and safety of afamelanotide and NB-UVB light in patients with vitiligo on the body and face versus NB-UVB light alone.

Conditions Studied

Vitiligo

Interventions

  • DRUG Afamelanotide and NB-UVB Light
  • PROCEDURE NB-UVB Light

Study Locations (20)

California

  • CLINUVEL site - Fresno
  • CLINUVEL site - Los Angeles
  • CLINUVEL site - Palo Alto
  • CLINUVEL site - San Diego

Florida

  • CLINUVEL site - Miami
  • CLINUVEL site - Miramar

Georgia

  • CLINUVEL site - Alpharetta
  • CLINUVEL site - Augusta

Minnesota

  • CLINUVEL site - Minneapolis
  • CLINUVEL site - Roseville

Alabama

  • CLINUVEL site - Birmingham

District of Columbia

  • CLINUVEL Site - Washington D.C.

Illinois

  • CLINUVEL site - Chicago

Louisiana

  • CLINUVEL site - Baton Rouge

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-10-11
Est. Completion 2026-06
Phase Phase 3

Sponsor

Clinuvel

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06109649

The ClinicalTrials.gov registry entry for NCT06109649 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,111-participant average among 15 other Vitiligo trials with a reported enrollment target (82% lower). The listed sponsor is Clinuvel, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vitiligo appearing as the primary indexed condition, and to 2 interventions - of which Afamelanotide and NB-UVB Light is the first listed.

NCT06109649 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT06109649 about?

NCT06109649 is a clinical study titled "A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo". The CUV105 study will assess the efficacy and safety of afamelanotide and NB-UVB light in patients with vitiligo on the body and face versus NB-UVB light alone.

What is the current status of trial NCT06109649?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2023-10-11. Estimated completion is 2026-06.

What conditions does trial NCT06109649 study?

This clinical trial studies the following conditions: Vitiligo.

What interventions are being tested in trial NCT06109649?

The interventions under investigation include: Afamelanotide and NB-UVB Light (DRUG), NB-UVB Light (PROCEDURE).

Who is sponsoring clinical trial NCT06109649?

This trial is sponsored by Clinuvel, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06109649 being conducted?

This trial has 20 study locations across Alabama, California, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Vitiligo

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Vitiligo

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.